Content Type: Article

  • Homework and Deadlines Matter: New IRS Pre-Audit Compliance Program for Retirement Plans

    Homework and Deadlines Matter: New IRS Pre-Audit Compliance Program for Retirement Plans

    ARTICLE / CLIENT ALERT

    Homework and Deadlines Matter: New IRS Pre-Audit Compliance Program for Retirement Plans

    June 16, 2022

    Read time: 3 min

    Key takeaways
    Overview

    Retirement plan sponsors should be aware of a new Internal Revenue Service (IRS) pilot program, which permits plan sponsors to conduct a pre-examination “check-up” of retirement plan administration before the IRS begins a plan examination. As part of the program, the IRS will send a letter notifying a plan sponsor that its retirement plan has been selected for an upcoming examination and give the plan sponsor 90 days to identify and voluntarily correct any compliance issues that may be self-corrected. Failure to respond by the 90-day deadline will result in an examination. Retirement plan sponsors who receive a pre-examination notice should immediately begin working with their lawyers and other advisors to determine the best way to respond to the IRS notice.

    PRE-EXAMINATION PILOT PROGRAM

    The IRS pre-examination compliance pilot program gives plan sponsors a chance to correct certain errors before an examination begins. If a plan sponsor identifies errors, then the plan sponsor may be able to self-correct using the procedures set forth in the IRS Employee Plans Compliance Resolution System (EPCRS) program, and the plan sponsor may notify the IRS of its corrective actions. If mistakes are not eligible for self-correction, the plan sponsor may request a closing agreement. With a closing agreement under the pilot program, the IRS will apply the Voluntary Correction Program (VCP) fee structure to determine the sanctions amount rather than the Audit CAP Program fees, which are unpredictable and typically higher. The IRS will review the plan sponsor’s corrective actions and determine whether it agrees that the plan sponsor appropriately corrected the mistakes. The IRS will then determine whether to issue a closing letter or to conduct a limited or full scope audit. The pilot program begins in June 2022.

    It’s not clear what factors the IRS will consider when determining whether to conduct a limited or full scope audit following a plan sponsor’s response. However, it stands to reason that a plan sponsor’s efforts at good faith compliance with the correction requirements may serve to limit the scope because typically the IRS wishes to promote self-correction efforts. It’s also not clear whether the 90-day pre-examination period will apply to all retirement plan audits or only to those randomly selected to be part of the pilot program.

    NEXT STEPS FOR PLAN SPONSORS

    Plan sponsors who receive a pre-examination notice should immediately begin working with their lawyers and other advisors to determine the best ways to respond to the IRS notice. If you receive an initial letter or have questions about the IRS compliance and correction programs, please contact your McDermott lawyer or the authors listed below.

    In depth
    Authors

    Jeffrey M. Holdvogt

    Partner

    Chicago

    More insights

  • Faked It? Your Contract Won’t Make It

    Faked It? Your Contract Won’t Make It

    ARTICLE

    Faked It? Your Contract Won’t Make It

    Jun 16, 2022

    Read time: 4 min

    Key takeaways
    Overview

    The US Court of Appeals for the Seventh Circuit affirmed a district court ruling denying a defendant’s motion to enforce an arbitration clause in a software license agreement that the defendant’s employee entered into using a fake company name at the defendant’s direction. CCC Intelligent Sols. Inc. v. Tractable Inc., Case No. 19-1997 (7th Cir. June 6, 2022) (Easterbrook, Brennan, St. Eve, JJ.)

    CCC Intelligent Solutions and Tractable are competitors that provide customers, including insurance companies, with cost estimates to repair damaged cars and trucks. Both companies supply software that applies algorithms to data generated by body shops and other repair centers. CCC provides the software to customers under terms in a license agreement. The license prohibits disassembling the software code or incorporating it into other software, forbids assignment of the license without CCC’s consent and includes a representation that the customer is not acting as an agent of any third party. The license also includes an arbitration clause. A Tractable employee obtained a license to CCC’s software under a fake business name, “JA Appraisal,” using a false mailing address and email address. The employee gave the software to Tractable, which disassembled the software and incorporated CCC’s proprietary algorithms into its own product. CCC became aware of Tractable’s improper use of its software and filed a lawsuit in the district court.

    Tractable moved to compel arbitration under the terms of the agreement, arguing that JA Appraisal was its agent and that Tractable was therefore a party to the license agreement. The district court denied Tractable’s motion. The district court found that a reasonable jury could find that CCC did not intend to grant Tractable a license, and that CCC could have reasonably believed it was doing business with JA Appraisal based on JA Appraisal’s representations and the agreement’s non-assignment provisions. Tractable appealed.

    The Seventh Circuit addressed whether Tractable was a party to the contract. The Court first assessed whether it was publicly known that Tractable did business under the JA Appraisal name. The Court found (and Tractable’s counsel admitted) that it was not possible for CCC to discover that Tractable used that name. Tractable, based on a comment to § 163 of the Restatement of Contracts, argued that § 163 provides that a party’s acceptance of a contract is not effective if it was induced by a misrepresentation of an essential term of the contract by the other party. The cited comment provides an exception to this rule, stating that “the mere fact that a party is deceived as to the identity of the other party” does not bring a case within the auspices of § 163 “unless it affects the very nature of the contract.”

    The Seventh Circuit rejected Tractable’s reliance on the comment. The Court found that JA Appraisal’s identity affected the very nature of the contract and therefore the exception recited in the comment did not apply. The Court explained that the exception to § 163 covers situations when a party failed to know the “full truth” about its trading partner. The Court pointed out that no such situation existed here because CCC did not know that Tractable would be its trading partner, particularly since Tractable told its employee to pretend to represent a small, independent appraiser. The Court explained that the laws governing the present dispute are so simple that Illinois courts have not revisited them in more than 80 years. The Court concluded that “Tractable is not a party to this contract, so it cannot demand arbitration.”

    Authors

    Paul Devinsky

    Senior Counsel

    Washington, DC

    More insights
    Endnotes

  • Preparing for the Demise of Roe v. Wade and the Criminalization of Abortion in Some US States: Practical Considerations for a Post-Roe World

    Preparing for the Demise of Roe v. Wade and the Criminalization of Abortion in Some US States: Practical Considerations for a Post-Roe World

    ARTICLE / CLIENT ALERT

    Preparing for the Demise of Roe v. Wade and the Criminalization of Abortion in Some US States: Practical Considerations for a Post-Roe World

    June 14, 2022

    Read time: 12 min

    Key takeaways
    Overview

    UPDATE: For the latest on the Supreme Court’s decision, please visit this article: The Overturning of Roe V. Wade


    Sometime in the next several weeks, the Supreme Court of the United States will issue its decision in Dobbs v. Jackson Women’s Health Organization (Dobbs). Based on the draft majority opinion authored by Justice Samuel Alito that was leaked to Politico in early May, there is a significant chance that the Court will overrule Roe v. Wade (Roe) and Planned Parenthood v. Casey (Casey) by holding that there is no federal constitutional right to obtain an abortion and leaving individual states free to substantially restrict abortion or prohibit abortion altogether.

    The effect of this likely decision on US companies would be substantial. Every US healthcare provider whose services include any aspect of family planning should give serious thought to how this likely new post-Roe reality will affect its offerings and operations. This includes not only those that provide pregnancy termination services (via surgical or pharmaceutical means, whether brick-and-mortar or telehealth/virtual), but also potentially those providing in vitro fertilization services, and conceivably even some contraceptive providers at some point down the line.

    Even companies that do not directly provide family planning or pregnancy termination services may be impacted by the likely demise of Roe, including:

    • Service providers and business associates of healthcare providers that furnish family planning or pregnancy termination services;
    • Anyone who provides abortion-related information or resources even outside of a patient-provider relationship (for example, companies that provide information regarding abortion access to employees or to the public);
    • Insurers who provide coverage for family-planning services;
    • Employers, health benefit plans and plan administrators, as we recently noted; and
    • Individuals and entities who invest in any of the above companies.

    There will continue to be a considerable degree of uncertainty about the reach of post-Roe abortion restrictions, given the lack of any recent enforcement history or judicial interpretation of many anti-abortion laws and the presence of competing laws in other states. It is also extremely likely that there will be further state legislation that could result in a wide variety of additional restrictions, which would meaningfully affect any risk analysis. In light of such uncertainty, organizations will want to stay in close touch with knowledgeable legal counsel to decide how to structure their operations, personnel and data going forward—especially if they currently (or intend to) provide or facilitate access to family planning services and do business or have personnel in any state that will further restrict or prohibit abortion in the wake of Dobbs.

    The right plan for a post-Roe reality will be different for each individual and organization that touches abortion or family planning services in any way.

    In depth

    What to expect

    Presently, Roe and Casey and their progeny prohibit state enforcement of any outright ban on abortion and any other measure that would create an “undue burden” on abortion access. If, as seems likely, those two decisions are fully overruled in the Dobbs decision, states largely will be free to restrict and/or prohibit abortion as their legislatures and governors choose—subject to any abortion-related provisions in their individual state constitutions.

    Many states have “trigger” or “zombie” abortion laws already on the books—prohibitions (or significantly tighter restrictions on abortions) that presently cannot be enforced but will spring (back) to life as soon as Roe and Casey are overturned. In some cases, enforcement of these statutes has explicitly been enjoined, but the issuance of a Supreme Court decision overturning Roe and Casey would instantaneously result in their (renewed) enforceability. Some other trigger laws include provisions that would slightly delay their effective dates (and enforceability) either by a specified number of days after a Supreme Court decision overruling Roe or until a state government actor (e.g., the state attorney general) certifies that Roe has been overruled. Where they exist, such provisions provide for some delay in enforcement but are measured in days or weeks rather than months or years. For example, Mississippi has a statute that requires the state’s Attorney General to determine whether the state’s trigger law would be considered constitutional following a Supreme Court decision overruling Roe before that law takes effect. And several other state legislatures are currently working on or have recently passed new legislation to prohibit or restrict abortion in a post-Roe world.

    A Texas Case Study: Texas is a high-profile example of a state with significant restrictions on abortion already in place as well as a trigger law that will spring to life if Roe and Casey are overturned. As many readers will know, Texas already has in place a unique “bounty” law that penalizes essentially all abortions after the existence of a detectable fetal “heartbeat” through the imposition of civil monetary damages (at least $10,000 per prohibited abortion, plus recovery of attorneys’ fees and other litigation costs)—but it can only be enforced by private litigants, not by government personnel. See Texas Health & Safety Code § 171. The Supreme Court declined to stay enforcement of this law in a “shadow docket” order earlier this term.

    Texas also has passed a trigger law that is extremely broad and provides plainly that “[a] person may not knowingly perform, induce, or attempt an abortion,” period (with a narrow exception where an abortion is necessary to prevent the death or significant health impairment of the pregnant woman, but no exceptions for, e.g., rape or incest situations). See Texas Health & Safety Code § 170A. “Abortion” for this purpose includes basically any means of intentionally “caus[ing] the death of an unborn child,” and “unborn child” is defined to include living embryo/fetus “from fertilization until birth.” See id. §§ 170A.001(1), 170A.001(5), 245.002(1) (emphasis added). In short, once an egg is fertilized, nearly anything done intentionally to prevent that fertilized egg from reaching live birth constitutes an abortion (although “birth control devices” and “oral contraceptives” are specifically excluded).

    Notably, Texas’s trigger law will have sharper teeth than its “bounty” law currently does. The plain language of the state’s trigger statute provides that, without Roe and Casey in place, any “perform[ance], induce[ment], or attempt” of a prohibited abortion in Texas could result in:

    • Criminal prosecution by the Attorney General or any one of the state’s 254 county district attorneys—for a first-degree felony if the abortion is successful, and a second-degree felony if it is unsuccessful (see Texas Health & Safety Code § 170A.004); plus
    • Civil enforcement by the Attorney General—seeking a civil penalty of at least $100,000 per unlawful abortion (plus recovery of attorneys’ fees and other litigation costs) (see id. § 170A.005); plus
    • Mandatory revocation of any “license, permit, registration, certificate, or other authority” held by a defendant physician or other health professional who violates the law (see id. § 170A.007).

    Under Texas criminal law, anyone who doesn’t personally perform, induce or attempt an unlawful abortion but causes, aids, conspires, solicits, etc., such conduct by someone else may also be at risk of felony prosecution. See Texas Penal Code §§ 7.02, 15.01-15.03. The question of how broadly Texas courts will define actions that may be considered to “induce” abortions also remains open. (Note that the law specifically exempts abortion patients, themselves, from being prosecuted or facing civil enforcement.)

    Post-Roe, these prohibitions clearly will apply to surgical abortions performed within Texas, and to the prescription, dispensing and administration of abortifacient medication if all occur within Texas. Their application to activities that occur outside of Texas is less clear, but individuals and organizations who provide abortion-related services to Texas residents from anywhere should seek counsel to determine whether, or in what way, these laws may be applied to their operations.

    ***

    Texas is just one such example among many states that will impose additional restrictions on abortions if Roe falls. At least 26 states have laws that could be used to restrict the legal status of abortion to various degrees and/or are generally viewed as being at high-risk for imposing additional restrictions post-Roe: Alabama, Arizona, Arkansas, Florida, Georgia, Idaho, Indiana, Iowa, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Montana, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, West Virginia, Wisconsin and Wyoming. The same is true of Puerto Rico and several other US territories. Kansas lawmakers also have expressed an intent to restrict abortion. For the rest of this article, we will collectively refer to these states as “Restrictive States.” See, e.g., “Abortion Policy in the Absence of Roe,” Guttmacher Institute, June 1, 2022; “What if Roe Fell?” Center for Reproductive Rights, last accessed June 10, 2022.

    Restrictive States’ laws carry a variety of potential risks for providers and those that facilitate access to or payment for family planning treatment, including (as illustrated in the Texas example above) the following: (1) risks to individual providers’ licenses, including revocation which could create a number of additional actions if that provider is licensed in multiple states; (2) civil penalties, which can include significant penalties per violation of the statute; and (3) criminal penalties, including felony treatment of some activities, which could result in imprisonment and criminal fines. As noted above, these penalties can, in some states, extend to individuals or companies that facilitate or pay for the treatment provided.

    On the other hand, some states have laws on the books that offer explicit protection to people seeking or providing access to abortion treatment or otherwise have codified a person’s right to privacy in such circumstances. This includes both state statutes and, in some instances, state constitutional protections. We will refer to states such as California, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, Oregon, Rhode Island and Washington, which have enacted varying degrees of state constitutional and statutory protection for abortion access, as “Protective States.” Specific post-Roe shield law efforts are also underway in many such Protective States, such as California, Connecticut, Massachusetts and New York.

    How to prepare

    Individuals and organizations that provide or facilitate abortion services, or other services that have the impact of preventing fertilized eggs from reaching birth, and those that invest in, service, compensate, or otherwise interact with such individuals or organizations, should monitor this situation very closely. It is changing rapidly and will continue to do so. In at least some of the Restrictive States, abortion will be outlawed (and potentially criminalized) the moment a Supreme Court decision overturning Roe and Casey is issued—i.e., likely around 10 am EDT on a weekday still to be determined in late June or early July.

    While each individual’s and organization’s situation will vary, here are some general ideas to consider:

    1. There will continue to be a considerable degree of uncertainty about the reach of post-Roe abortion restrictions, given the lack of any recent enforcement history or judicial interpretation and the presence of competing laws in other states. It is also extremely likely that there will be further state legislation in Restrictive States that could result in a wide variety of additional restrictions which would meaningfully affect any risk analysis. In light of such uncertainty, organizations should stay in close touch with knowledgeable legal counsel to decide how to structure their conduct going forward—especially if they currently (or intend to) provide or facilitate access to family-planning services and do business or have employees in any of the Restricted States. Employment/benefits, privacy, healthcare regulatory, subpoena response and litigation/enforcement defense will be among several areas of law that will be relevant to such planning.
    2. Regardless of your company’s goals and risk appetite, consult counsel to consider risk mitigation and management strategies, particularly in Restrictive States where providing or facilitating abortions will be criminalized. This may include reducing ties to Restrictive States and considering what level of legal shields may be available in Protective States for individuals, corporate entities, assets and data.
    3. Some organizations that are headquartered or incorporated in Protective States may be required under the Protective States’ laws to provide certain benefits and coverages even for those employees living in Restrictive States. Any such obligations should be confirmed and tracked closely.
    4. Carefully consider what information or data you collect and maintain that may be abortion-related. Organizations with information about patients who obtain abortion-related services or about individuals who provide or facilitate such services should be prepared for increased scrutiny of such data, including additional subpoenas and other requests. Similarly, it is worth reviewing all privacy-related policies, procedures, notices and disclosures to ensure current factual accuracy and to ensure the company is prepared to handle subpoenas and other information requests when they arrive. Companies should also consider whether internal policies, procedures and training for personnel should be modified or implemented related to the consequences of disclosing confidential company information and the potential consequences of noncompliance with company policies and procedures.
    5. Companies are strongly encouraged to involve in-house or outside counsel directly in strategy and planning discussions so they are protected by the attorney-client privilege as much as possible. Companies should also be thoughtful about public statements (internally or externally).

    The right mix of steps to navigate a likely post-Roe reality will be different for each individual and organization. Our multidisciplinary team of Healthcare, Employee Benefits, Privacy, Transactions, Litigation and White-Collar lawyers is monitoring the rapidly evolving situation closely and is helping clients of various types assess their risks and options to plan their best paths forward. Please do not hesitate to contact the authors or another contact at our firm.

    Authors

    Stacey L. Callaghan

    Partner

    Chicago

    Dana M. McSherry

    Partner

    Boston

    Caroline Reignley

    Partner

    Washington, DC

    Paul M. Thompson

    Partner

    Washington, DC

    Sarah G. Raaii

    Partner

    Chicago

    More insights

  • Proposals to Reform the UK Data Protection Regime

    Proposals to Reform the UK Data Protection Regime

    ARTICLE / CLIENT ALERT

    Proposals to Reform the UK Data Protection Regime

    June 15, 2022

    Read time: 3 min

    Key takeaways
    Overview

    On 10 May 2022 and as part of the Queen’s speech, which sets out the programme of legislation for the forthcoming parliamentary session, the government announced proposals to table a Data Reform Bill (the Bill) to reform the UK’s data protection regime and to diverge from European GDPR1. This follows the consultation by the Department for Digital, Culture, Media and Sport (DCMS) consultation released last September.

    In depth

    The UK government has stated that the purpose of the Bill is to reduce red tape and encourage innovation, modernise the Information Commissioner’s Office, and improve appropriate access to data in health and social care contexts by designing a more flexible approach, focused on privacy outcomes rather than box-ticking exercises.

    The Government proposes to2:

    • Remove some obligations, such as to:
      • appoint a data protection officer;
      • conduct data protection impact assessments;
      • consult with the Information Commissioner in relation to high-risk processing; and
      • prepare records of processing activities.
    • Allow broader use of data for research and AI projects, or  consolidating the research provisions in the UK GDPR and Data Protection Act 2018 to provide more clarity. [Please note that the ICO have recently issued a draft guidance on the processing for research purposes. More information on this can be found in the article from Lexology, “ICO draft guidance and consultation – health data];
    • Change the law to enable public authorities to share personal data for specific purposes, such as public health purposes; and
    • Reform the Information Commissioner’s Office to enhance its enforcement powers but also to make it more accountable to the Parliament and public.

    The DCMS analysis indicates that the proposed reforms will create over £1 billion in business savings over ten years by reducing burdens on businesses of all sizes3. Despite the revolutionary tone of these announcements, the UK will still likely wish to ensure that the reform does not lessen the protection of personal data and thus does not impact the EU adequacy decision, which enables the free transfer of personal data from the EU to the UK.

    It may take some time before the Bill is tabled. At the same time, there seem to be some parallels on approach on the European front. On 3 May, the European Commission launched the European Health Data Space (EHDS) which aims to foster a single market for digital health services and products. Part of the EHDS strategy is improving the use of health data for research, innovation and policymaking4.

    Authors

    Sharon Lamb

    Partner

    London – 22 Bishopsgate

    More insights

  • Healthcare Regulatory Check-up Newsletter | May 2022

    Healthcare Regulatory Check-up Newsletter | May 2022

    ARTICLE / REPORT

    Healthcare Regulatory Check-up Newsletter | May 2022

    June 10, 2022

    Read time: 2 min

    Overview

    This issue of McDermott’s Healthcare Regulatory Check-Up highlights notable enforcement activity between April 21 and May 20, 2022, including a telemedicine case involving $64 million in false and fraudulent claims. We also review recent Office of Inspector General (OIG) advisory opinions on provider donations to a patient assistance program and a laboratory’s proposed arrangement with hospitals, plus OIG’s four new Work Plan items.

    Recent Centers for Medicare & Medicaid Services (CMS) activity of note includes a proposed rule on the fiscal year (FY) 2023 Inpatient Prospective Payment System and new databases detailing change-of-ownership information for Medicare-enrolled hospitals and skilled nursing facilities. CMS also recently released the FY 2023 Skilled Nursing Facility Prospective Payment System proposed rule, which includes provisions seeking to advance the Biden administration’s efforts to improve competition, transparency and quality for hospitals and nursing homes.

    In depth
    Tabs

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Kelsey R. Reinhardt

    Associate

    Los Angeles

    Monica Wallace

    Partner

    Chicago

    More insights
    Endnotes

  • New SEC Rule Mandates Electronic Filing of Form 144s and “Glossy” Annual Reports

    New SEC Rule Mandates Electronic Filing of Form 144s and “Glossy” Annual Reports

    ARTICLE / CLIENT ALERT

    New SEC Rule Mandates Electronic Filing of Form 144s and “Glossy” Annual Reports

    June 10, 2022

    Read time: 5 min

    Key takeaways
    Overview

    On June 3, 2022, the US Securities and Exchange Commission (SEC) adopted amendments to Rule 101 of Regulation S-T that eliminate the option for issuers and filing persons to file a number of forms in paper format. The amendments mandate that issuers and filing persons electronically submit the following forms on EDGAR:

    • Form 144 for sales of securities of issuers subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act
    • “Glossy” annual reports to security holders
    • Form 6-K filings[1]
    • Notices of exempt solicitations and exempt preliminary roll-up communications
    • Filings made by multilateral development banks
    • Certifications made pursuant to Section 12(d) of the Exchange Act and Exchange Act Rule 12d1-3 that a security has been approved by an exchange for listing and registration.
    In depth

    FORM 144

    The amendments have important implications for Form 144 filers as the SEC is looking to increase transparency and make these filings more accessible to investors, analysts and other market participants. According to data cited by the SEC, less than 1% of Form 144s submitted are done so electronically. The balance of Form 144s are either submitted in paper format or via email by virtue of the filing relief initially adopted during the COVID-19 pandemic.[2] The paper forms are not digitized by the SEC but are instead kept in its Public Reading Room in Washington, DC. Handwritten and offline, paper Form 144s are difficult for the public to access, track and analyze. Third-party service providers routinely scan the paper filings and make them available to their subscribers. However, the SEC noted that these third-party services are subscription based and not generally accessible to the public without charge. The SEC also noted the lag between the time the filings are made and when they become available via third-party service providers, with several days’ lag being the norm. Form 144 will now be an online fillable document similar to Forms 3, 4 and 5, making all filings machine readable and easily accessible online.

    Of particular note to filing persons, in order to submit a Form 144 electronically, they will need to obtain EDGAR access codes, a process that typically requires 48 to 72 hours lead time. Several commentators to the original rule proposal noted this increased compliance burden, much of which will be borne by the brokerage firms that execute trades on their clients’ behalf. However, the SEC concluded that the benefit of greater transparency outweighed the burden on filing persons and their advisors.

    Filers often submit Form 144s in tandem with trades executed in 10b5-1 plans. Although these amendments increase transparency for such filers, other proposed amendments relating to 10b5-1 plans, including the anticipated mandatory “cooling off period” and prohibition against overlapping plans, have not yet been adopted.

    “GLOSSY” ANNUAL REPORTS

    The newly adopted amendments also mandate issuers to electronically submit their “glossy” annual reports to the SEC. Historically, issuers have been required to submit their “glossy” annual reports in paper format. In 2016, SEC staff adopted interpretive guidance that allowed issuers to satisfy their delivery obligations by posting their “glossy” annual reports on their corporate websites. Contemporaneously with the effectiveness of the new rules, the interpretive guidance will be withdrawn and, while issuers may continue to post their “glossy” annual reports online, doing so will not satisfy their SEC delivery obligations. Going forward, issuers will need to electronically submit a PDF of their “glossy” annual reports on EDGAR.

    FORM 11-K FINANCIAL STATEMENTS

    The SEC is also making technical changes to how issuers submit Form 11-K financial statements and any accompanying notes. The amendments require that Form 11-K financial statements and accompanying notes be filed using Inline XBRL. The change brings Form-11-K financial statements in line with the requirements already in place for financial information in Forms 10-K, 20-F and 40-F.

    TIMELINE FOR IMPLEMENTATION

    The amendments will become effective 30 days after being published in the Federal Register. However, the SEC is providing a transition period to allow first-time EDGAR filers to apply for their filing codes and to allow traditionally paper filers to prepare to submit the following documents electronically on EDGAR:

    • All documents newly required to be submitted electronically: Filers have six months after the amendments’ effective date to submit all documents that are newly mandated to be submitted electronically (except for Form 144).
    • Form 144: The requirement to file Form 144s electronically will commence six months from the date of publication in the Federal Register of the SEC release that adopts the version of the EDGAR Filer Manual addressing updates to Form 144. (Note: The SEC will consider adoption of the relevant version of the EDGAR Filer Manual that addresses updates to Form 144 in September 2022. Publication in the Federal Register would occur thereafter.)
    • Form 11-K Financial Statements: Filers have three years after the amendments’ effective date to comply with the use of Inline XBRL for 11-K financial statements and accompanying notes.

    For more information, see the Final Rule and the SEC Fact Sheet.

    Riley O’Farrell, a summer associate in the Chicago office, also contributed to this article.

     

    Authors

    Eric Orsic

    Partner

    Chicago

    More insights

  • Russian Sanctions Update: OFAC Issues Broad Restrictions on ‘New Investment’ in Russia

    Russian Sanctions Update: OFAC Issues Broad Restrictions on ‘New Investment’ in Russia

    ARTICLE / CLIENT ALERT

    Russian Sanctions Update: OFAC Issues Broad Restrictions on ‘New Investment’ in Russia

    June 10, 2022

    Read time: 15 min

    Key takeaways
    Overview

    On June 6, 2022, the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) issued new and amended Frequently Asked Questions (the “FAQs”) setting forth what constitutes a prohibited “new investment” in the Russian Federation for purposes of the Russian Harmful Foreign Activities Sanctions program.[1]

    The FAQs provide long-awaited guidance with respect to three Executive Orders (“E.O.s”) issued earlier this year by President Biden under the Russia sanctions program. All three E.O.s include some form of restriction on “new investment” in Russia by U.S. persons. E.O. 14066, issued March 8, 2022, prohibits “new investment in the energy sector in the Russian Federation”; E.O. 14068, issued March 11, 2022, gives the Secretary of the Treasury authority to prohibit “new investment in any sector of the Russian Federation”; and E.O. 14071, issued April 6, 2022—the broadest and most consequential ban—prohibits “new investment in the Russian Federation” as a whole, regardless of sector.[2]

    The FAQs take a broad interpretation of “new investment” and will have a significant impact on U.S. market participants, especially those operating in the capital markets. Among other things, the FAQs ban U.S. persons from purchasing both new and existing debt and equity securities issued by any entity in Russia. They also ban U.S. persons from lending funds to, or purchasing an equity interest in, entities located outside of Russia under certain circumstances.

    While providing important guidance and much-needed clarity as to the “new investment’ prohibition, the FAQs at the same time leave the scope of the prohibition unclear in many respects and create new ambiguities as to how it applies in particular instances.

    We discuss some key takeaways from the FAQs below.

    What is meant by the term “new investment” for purposes of the E.O.s?

    FAQ 1049[3] states that, for the E.O.s’ purposes, “investment” means “the commitment of capital or other assets for the purpose of generating returns or appreciation.” “New investment,” in turn, means ”a commitment made on or after the effective date of the [applicable] E.O.[‘s] prohibitions” (“New Investment”). OFAC specifically notes that New Investments include both investments made pursuant to an agreement entered into on or after the effective date of the applicable E.O.’s prohibitions (“Effective Date”) and the exercise of rights under an agreement, even if entered into before the Effective Date, where the commitment itself is made on or after the Effective Date. “Maintenance” of an investment made prior to the applicable effective date, however, is permissible.[4]

    To illustrate these definitions, OFAC provides the following lists of transactions that, respectively, do and do not constitute New Investments:[5]

    New Investments include:

    • The purchase or acquisition of real estate in the Russian Federation, other than for noncommercial, personal use; 
    • Entry into an agreement requiring the commitment of capital or other assets for the establishment or expansion of projects or operations in the Russian Federation, including the formation of joint ventures or other corporate entities in the Russian Federation;
    • Entry into an agreement providing for the participation in royalties or ongoing profits in the Russian Federation;
    • The lending of funds to persons located in the Russian Federation for commercial purposes, including when such funds are intended to be used to fund a new or expanded project or operation in the Russian Federation;
    • The purchase of an equity interest in an entity located in the Russian Federation;[6] and
    • The purchase or acquisition of rights to natural resources or exploitation thereof in the Russian Federation.

    New Investments DO NOT include:

    • Entry into, performance of or financing of a contract to sell or purchase goods, services or technology to or from an entity in the Russian Federation pursuant to ordinary commercial sales terms (g., a payment of an invoice for goods, where payment is made within the contracted time period and such payment does not involve participation in royalties or ongoing profits);
    • Maintenance[7] of an investment in the Russian Federation provided the investment was made prior to the Effective Date, including maintenance of pre-existing entities, projects or operations in the Russian Federation and their associated tangible property; and
    • Wind down or divestment of a pre-existing investment, such as a pre-existing investment in an entity, project or operation, including any associated tangible property, located in the Russian Federation.[8]

    Are U.S. persons prohibited from purchasing debt or equity securities issued by an entity in the Russian Federation?

    Yes, FAQ 1054 states that the E.O.s “prohibit U.S. persons from purchasing both new and existing debt and equity securities issued by an entity in the Russian Federation.”[9] Notably, the FAQ’s reference to “existing” debt and equity securities indicates that even purchases of securities in the secondary market—where the issuer does not receive the proceeds of the sale—are prohibited as a form of “new investment.”

    OFAC has not provided guidance as to what it means for an entity to be “in” or “located in” Russia. Two relevant considerations are likely to be where the entity is incorporated or organized and where it has its headquarters or principal place of business. However, other facts and circumstances may also be relevant.

    FAQ 1054 permits U.S. persons to sell or divest (or facilitate the sale or divestment of) debt or equity securities issued by an entity in the Russian Federation, so long as the purchaser is a non-U.S. person.[10] OFAC highlights that there is no requirement for U.S. persons to divest such securities; rather, U.S. persons “may continue to hold such previously acquired securities.”

    In addition, the FAQ states that “the conversion of depositary receipts to underlying local shares of non-sanctioned Russian issuers” will not run afoul of the New Investment restrictions. OFAC has not specified whether the term “non-sanctioned Russian issuers” is intended to encompass only Russian companies designated as Specially Designated Nationals (“SDNs”) or also Russian companies on the Sectoral Sanctions Identifications (“SSI”) List.

    OFAC further clarifies that “the purchase of shares in a U.S. fund that contains debt or equity securities issued by entities in the Russian Federation” would not generally constitute a prohibited New Investment provided the debt or equity securities issued by the Russian Federation entity “represent less than a predominant share by value of the fund’s debt or equity securities”[11] and the transactions do not involve blocked persons and are not otherwise prohibited (unless exempt or otherwise authorized by OFAC).

    Neither FAQ 1054 nor any of the other FAQs released on June 6 specifically addresses derivative instruments. FAQ 1054’s prohibition on purchasing securities “issued” by an entity in the Russian Federation suggests that a cash-settled derivative whose value is tied to securities issued by a Russian entity, but does not involve the purchase of any securities issued by the entity, falls outside the scope of the New Investment prohibition.

    Are U.S. persons prohibited from lending funds to, or purchasing an equity interest in, entities located outside of the Russian Federation?

    No, according to FAQ 1055, provided that (1) the funds are not specifically intended for new projects or operations in the Russian Federation and (2) the target entity’s revenues are not “predominantly derived from its investments in the Russian Federation.”[12] Therefore, even a loan to, or a purchase of an equity interest in, a non-Russian entity may constitute prohibited New Investment if either of these conditions apply. OFAC has not provided guidance on what it means for an entity’s revenues to be “predominantly derived” from investments in Russia.

    FAQ 1055 further provides that U.S. persons, including financial institutions, “may reasonably rely upon the information available to them in the ordinary course of business” for purposes of assessing whether a potential transaction meets the aforementioned criteria.

    Do the New Investment FAQs affect trading in Russian sovereign debt?

    Yes. Previously, OFAC had issued Directives and related FAQs making clear that U.S. persons are prohibited from participating in the primary market for Russian sovereign debt (whether ruble or non-ruble denominated) and from participating in the secondary market for Russian sovereign debt issued after March 1, 2022. OFAC permitted U.S. persons to participate in the secondary market for Russian sovereign debt issued prior to March 1, 2022. However, the ability of U.S. persons to receive interest, dividend or maturity payments on Russian sovereign debt came to an end on May 25, 2022, when a general license allowing receipt of such payments expired.[13]

    FAQ 1054 now prohibits U.S. persons from purchasing “existing debt . . . securities” issued “by an entity in the Russian Federation.” As this prohibition encompasses bonds issued by the Russian Central Bank, National Wealth Fund and Ministry of Finance (the issuers of Russian sovereign debt), it appears that U.S. persons may no longer purchase such bonds even if the bonds were issued prior to March 1, 2022. As part of the actions taken on June 6, OFAC updated a previously issued FAQ relating to Russian sovereign debt to note that the New Investment prohibitions of the E.O.s now “prohibit U.S. persons from purchasing debt and equity securities issued by an entity in the Russian Federation.”[14]

    What types of transactions are excluded from the E.O.s’ prohibitions on New Investments as permissible maintenance activities?

    A New Investment “generally excludes the maintenance of investments in the Russian Federation” made prior to the Effective Date, i.e., “pre-existing projects or operations,”[15] provided such activities do not involve blocked persons or other prohibited transactions (unless exempt or otherwise authorized by OFAC). To illustrate, OFAC provides the following examples of investment maintenance (“Maintenance”):

    • Transactions to ensure continuity of pre-existing projects or operations within the Russian Federation, including payments to employees, suppliers, landlords, lenders and partners;
    • The preservation and upkeep of pre-existing tangible property in the Russian Federation; and
    • Activities associated with maintaining pre-existing capital investments or equity investments.

    All transactions “ordinarily incident to” performance under a pre-existing agreement, i.e., an agreement that was already in place before the Effective Date, as long as these transactions are “consistent with previously established practices and support pre-existing projects or operations,” and do not expand pre-existing projects or operations beyond those already underway prior to the Effective Date, even where such expansion is contemplated in the pre-existing agreement. Commitments pursuant to the exercise of rights are similarly prohibited if made subsequent to the Effective Date. When assessing whether activity is consistent with past practice, OFAC will take into account “all relevant facts and circumstances,” including the transaction history between the contracting parties.

    Additionally, OFAC provides that U.S. persons are permitted to “modify or alter pre-existing agreements, or enter into new contracts or agreements” where any transactions pursuant to such contracts or agreements are “consistent with previously established practices” and “support pre-existing projects or operations.” By way of example, FAQ 1050 provides that “a pre-existing agreement may be modified, or new contract established, to substitute suppliers, conduct maintenance or repairs, or comply with new environmental or safety standards.”

    Are imports and exports of goods, services or technology from the Russian Federation considered to be New Investments?

    The E.O.s’ prohibitions on New Investments do not include “the export or import of goods, services, or technology, or related sales or purchases, to or from the Russian Federation” provided the underlying transaction is made pursuant to “ordinary commercial sales terms,” e.g., a one-time payment for goods, within a determined time period, with no “ongoing participation in royalties or ongoing profits.”[16] Such transactions may also be conducted through commercial letters of credit, documentary collections or other traditional trade finance products, provided U.S. persons are not otherwise prohibited from entering into new contracts or agreements for such transactions.[17]

    Can U.S. entities continue to fund their subsidiaries’ or affiliates’ pre-existing projects or operations in the Russian Federation?

    Yes, provided that the subsidiary or affiliate utilizes such funds for Maintenance purposes only.[18] OFAC reiterates that “U.S. persons may not fund new or expanded projects or operations undertaken by their subsidiaries and affiliates located in the Russian Federation” after the Effective Date.

    Are transactions related to divestment permissible?

    Transactions “related to the divestment or the facilitation of divestment of a pre-existing investment” in the Russian Federation, such as a pre-existing investment in entities, projects or operations, are not prohibited as New Investments provided no blocked persons are involved and the transactions are not prohibited elsewhere (unless specifically exempt or authorized by OFAC).[19]

    FAQ 1053 also provides that facilitating “the wind down or divestment of an existing investment in the Russian Federation” is similarly permissible, but only on behalf of the selling party. By way of example, OFAC provides that a U.S. financial institution may advise a seller in a divestment transaction concerning the sale of its equity interest in an entity located in the Russian Federation. However, OFAC notes that U.S. persons are prohibited from “providing any approval, financing, facilitation, or guarantee” to a non-U.S. buyer seeking to acquire an equity interest in any entity located in the Russian Federation.[20]

    Schulte Roth & Zabel’s lawyers are available to assist you or address any questions you may have regarding these developments. Please contact the Schulte Roth & Zabel lawyer with whom you usually work, or any of the following attorneys:

    Gary Stein

    Betty Santangelo – New York (+1 212.756.2587, betty.santangelo@srz.com)

    Melissa G.R. Goldstein – Washington, DC (+1 202.729.7471, melissa.goldstein@srz.com)

    Hannah M. Thibideau – New York (+1 212.756.2382, hannah.thibideau@srz.com)

    Hadas A. Jacobi – New York (+1 212.756.2055, hadas.jacobi@srz.com)

    Angela Garcia – New York (+1 212.756.2359, angela.garcia@srz.com)


    [1] For prior Schulte Roth & Zabel Alerts relating to the Russia sanctions program, see Russian Sanctions Update: FinCEN and NYDFS Issue Guidance (April 25, 2022), available at /insights/russian-sanctions-update-fincen-and-nydfs-issue-guidance/; Sanctions Update: U.S. Imposes Sweeping Sanctions Against Russia and Belarus (Feb. 28, 2022), available at /insights/sanctions-update-u-s-imposes-sweeping-sanctions-against-russia/; and Sanctions Update: US Begins to Roll Out Sanctions Against Russia (Feb. 22, 2022), available at /insights/sanctions-update-u-s-begins-to-roll-out-sanctions-against-russia/. 

    [2] See Exec. Order No. 14066, 87 Fed. Reg. 47 (March 8, 2022), available at https://home.treasury.gov/system/files/126/eo_14066.pdf; Exec. Order No. 14068, 87 Fed. Reg. 50 (March 11, 2022), available at https://home.treasury.gov/system/files/126/14068.pdf; and Exec. Order No. 14071, 87 Fed. Reg. 68 (April 6, 2022), available at https://home.treasury.gov/system/files/126/14071.pdf.

    [3] OFAC FAQ 1049 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1049.

    [4] Id. OFAC provides examples of such “maintenance” in FAQ 1050 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1050, which this Alert discusses below. OFAC also reiterates that even if a transaction does not constitute a “New Investment” pursuant to the applicable E.O., “U.S. persons engaging in the transaction must comply with all other relevant sanctions prohibitions, including those pursuant to Ukraine/Russia-Related Sanctions Regulations and Russian Harmful Foreign Activities Sanctions Regulations.” FAQ 1049, id., citing, e.g., OFAC FAQ 415 (Nov. 28, 2017), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/415. By way of example, FAQ 1049 notes that the E.O.s prohibit “any approval, financing, facilitation, or guarantee by a United States person, wherever located, of a transaction by a foreign person where the transaction by that foreign person would be prohibited if performed by a United States person or within the United States.” Id., citing OFAC FAQ 1053 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1053.

    [5] Unless exempt or otherwise authorized by OFAC. Id.

    [6] Id., citing OFAC FAQ 1054 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1054, and OFAC FAQ 1055 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1055 (both of which are discussed below).

    [7] See FAQ 1050, supra note 4 (discussed below).

    [8] FAQ 1049, supra note 3, citing FAQs 1053 and 1054, supra notes 4 and 6, respectively.

    [9] FAQ 1054, supra note 6.

    [10] Id., citing FAQs 1049 and 1053, supra notes 3 and 4, respectively.

    [11] See id. (“the purchase of shares in a U.S. fund that contains debt or equity securities issued by entities in the Russian Federation generally would not be considered a prohibited ‘new investment,’ under the respective E.O.s, so long as these holdings represent less than a predominant share by value of debt or equity securities issued by entities in the Russian Federation”).

    [12] FAQ 1055, supra note 6.

    [13]OFAC, Directive 1A under E.O. 14024, 87 Fed. Reg. 32303 (Feb. 22, 2022), available at https://home.treasury.gov/system/files/126/russia_directive_1a.pdf; OFAC FAQ 1005 (as released on Mar. 2, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1005; OFAC, General License 9A (Authorizing Transactions Related to Dealings in Certain Debt or Equity), 31 CFR part 587 (Mar. 2, 2022), available at https://home.treasury.gov/system/files/126/russia_gl9a.pdf.

    [14] OFAC FAQ 1005 (as updated on June 6, 2022), available at  https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1005.

    [15] FAQ 1050, supra note 4.

    [16] OFAC FAQ 1051 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1051, citing FAQ 1049, supra note 3.

    [17] Id. The FAQ specifically notes that “U.S. persons are prohibited or restricted by law from exporting, reexporting, or importing certain goods and services involving the Russian Federation,” including pursuant to E.O. 14068 § 1(a)(i), supra note 2. FAQ 1051 also points to OFAC FAQ 415 (Nov. 28, 2017), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/415, which clarifies how prohibitions and exemptions under one Directive affect prohibitions and exemptions under another for persons determined to be subject to multiple Directives.

    [18] OFAC FAQ 1052 (Jun. 6, 2022), available at https://home.treasury.gov/policy-issues/financial-sanctions/faqs/1052.

    [19] FAQ 1053, supra note 4. OFAC reiterates that the E.O.s prohibit “any approval, financing, facilitation, or guarantee by a United States person, wherever located, of a transaction by a foreign person where the transaction by that foreign person would be prohibited if performed by a United States person or within the United States.” Id.

    [20] U.S. persons are also permitted to advise on the requirements of U.S. sanctions laws consistent with OFAC’s Guidance on the Provision of Certain Services Relating to the Requirements of U.S. Sanctions Laws. Id. OFAC’s guidance is available at https://home.treasury.gov/system/files/126/compliance_services_guidance.pdf.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2022 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Betty Santangelo

    Counsel

    New York – 919 Third Avenue

    Melissa G.R. Goldstein

    Partner

    New York – 919 Third Avenue

    More insights

  • Lawmakers Unveil Draft Version of the American Data Privacy and Protection Act

    Lawmakers Unveil Draft Version of the American Data Privacy and Protection Act

    ARTICLE / CLIENT ALERT

    Lawmakers Unveil Draft Version of the American Data Privacy and Protection Act

    June 7, 2022

    Read time: 6 min

    Key takeaways
    Overview

    With time running out in this US Congress, and with midterms around the corner, a bipartisan group of legislators is making what may be a last-gasp attempt at a federal privacy law compromise. On June 3, 2022, House Energy and Commerce Committee Chair Rep. Frank Pallone (D-NJ), Ranking Member Rep. Cathy McMorris Rodgers (R-WA) and Senate Commerce, Science and Transportation Committee Ranking Member Sen. Roger Wicker (R-MS) released a draft of a new comprehensive federal privacy bill, the American Data Privacy and Protection Act (ADPPA). Notably absent from this list of potential sponsors is Sen. Maria Cantwell (D-WA), Chair of the Senate Commerce Committee, who had been given the OK by Sen. Chuck Schumer (D-NY) to attempt to pass federal privacy legislation. Shortly after its release, Senator Cantwell criticized the ADPPA and signaled that she had her own competing proposal. Senator Cantwell’s position, plus the absence of any California Representative or Senator, signals that the ADPPA is likely destined to stall on the hill like each of its predecessors.

    Nonetheless, with the steady drip of new state consumer privacy laws, many businesses are growing anxious and waiting for action at the federal level, so the ADPPA is noteworthy. This On the Subject highlights several notable features of the ADPPA beyond the anticipated consumer rights of access, correction, deletion and portability. We will start with a look at the private right of action and pre-emption in the ADPPA, as those have traditionally been the sticking points in the federal privacy law debate.

    In depth
    • Limited private right of action: Beginning four years after the ADPPA’s effective date, individuals and classes will gain a private right of action, but it is a proscribed right. Notably, there are no statutory damages. While a successful plaintiff can still recover attorneys’ fees, plaintiffs are only permitted to seek injunctive or compensatory damages. The lack of statutory damages may serve to dampen the plaintiffs’ bar’s interest in bringing ADPPA cases in the first instance. A further deterrent to the private right of action are the procedural prerequisites to suit. First, the allegedly aggrieved person will first have to give notice to the Federal Trade Commission (FTC) and their relevant state Attorney General of the alleged wrong to see if either regulator wants to pursue the action. Absent action by these regulators, the allegedly aggrieved person must then give notice to the prospective defendant and give them 45 days to cure the alleged harm before filing suit.
    • Federal pre-emption with more than some carve-outs: One of the things that businesses are looking for in a federal privacy bill is strong state pre-emption so that businesses can focus on complying with one law and related regulations. The ADPPA creeps closer to that objective, but not by much. There is a broad statement of pre-emption of state laws, but then that pre-emption is effectively gutted by a page-and-a-half long list of state laws that are not pre-empted, including California’s California Consumer Privacy Act (CCPA) and Illinois’ Biometric Information Privacy Act (BIPA).
    • Broad Definition of “Sensitive” Data: The ADPPA would categorize a large swath of information as “sensitive” that may not immediately come to mind as being particularly sensitive. For example, “information identifying an individual’s online activities over time or across third party websites or online services.” In effect, this is cookie data. This definition, paired with an affirmative opt-in obligation for the collection of “Sensitive” data, means that the ADPPA would bring many of the requirements of Europe’s ePrivacy Directive to the United States.
    • Proscriptive Duty of Loyalty: While the ADPPA’s “duty of loyalty” is not the same kind of fiduciary duty that other legislators have attempted to introduce, it is nonetheless quite prescriptive, including a list of eight practices that businesses should not engage in, ranging from the collection and use of Social Security numbers to the transfer of aggregated internet search or browser histories.
    • Targeted Marketing: Similar to other privacy legislation, the ADPPA would require that businesses allow opt-outs from targeted marketing, including intra-corporate family targeted marketing. The ADPPA would also prohibit the delivery of targeted marketing to anyone under the age of 17.
    • Third-Party Collectors Registration: The ADPPA would require third parties who collect information about consumers, but who lack direct contact with that consumer, to file registration and offer certain public disclosures about their practices.
    • Executive Responsibility: Beginning one year after the ADPPA becomes effective, the chief executive officer, the chief privacy officer and the chief information security officer of what the ADPPA defines as “large data holders” would have to certify compliance with the ADPPA to the FTC. This puts these individuals in direct line for potential liability if their company does not, in fact, comply with the ADPPA. A large data holder is an entity that has annual gross revenues of $250 million or more and collects or transfers the personal information of five million or more individuals or devices or the sensitive data of 100,000 individuals or devices.
    • Impact Assessments and Algorithms: Impact assessments would be required for a number of processing activities under the ADPPA, including with respect to any algorithm of a large data holder that uses personal information.
    • Small Business Exemption: In addition to the anticipated exemptions to the ADPPA (e.g., the Gramm–Leach–Bliley Act, the Fair Credit Reporting Act, the Health Insurance Portability and Accountability Act), the ADPPA includes a limited exemption for businesses that for the prior three calendar years (or for the period in which the entity has been existence if less than 3 years) had (i) annual revenue of less than $41 million, (ii) did not collect or process the data of more than 100,000 individuals and (iii) did not derive more than 50% of its revenue from transferring personal information.

    Ultimately, while the ADPPA represents another important step forward by signaling that compromise on the two key sticking issues of pre-emption and a private right of action is possible, the bill still has a long way to go before becoming law. With Senator Cantwell likely to introduce a competing bill and with the calendar where it is, it looks like the issue of federal privacy legislation may be left to a subsequent Congress.

    McDermott’s Global Privacy & Cybersecurity team is always keeping up with the latest changes in the legislative landscape and future-proofing our clients for changes to come. For assistance, please contact Amy Pimentel or David Saunders.

    John Ying, a summer associate in the Atlanta office, also contributed to this article.

    Authors

    David P. Saunders

    Partner

    Chicago

    More insights

  • Biden Administration Pauses Solar Panel Circumvention Proceeding to Allow Domestic Industry to Develop Sufficient Supply of Solar Modules

    Biden Administration Pauses Solar Panel Circumvention Proceeding to Allow Domestic Industry to Develop Sufficient Supply of Solar Modules

    ARTICLE / CLIENT ALERT / US POLICY

    Biden Administration Pauses Solar Panel Circumvention Proceeding to Allow Domestic Industry to Develop Sufficient Supply of Solar Modules

    June 6, 2022

    Read time: 6 min

    Key takeaways
    Overview

    In an unprecedented move, US President Joe Biden has decided to do the following:

    1. Temporarily pause the imposition of any duties or estimated duties that might result from the US Department of Commerce’s (Commerce) pending inquiry into whether crystalline silicon photovoltaic cells and modules (CSPVs) from Cambodia, Malaysia, Thailand or Vietnam (the target countries) are circumventing antidumping and countervailing duty orders on CSPVs from China; and
    2. Take action to increase the capability to produce CSPVs and components of CSPVs in the United States, as well as increase demand for such products.

    Both aspects of the President’s announcement are discussed below.

    In depth

    RELIEF FROM CIRCUMVENTION INQUIRY

    Invoking a “state of emergency”[1] based on “threats to the availability of sufficient electricity generation capacity,” President Biden directed the Secretary of Commerce to take appropriate action to permit the importation of certain solar cells and modules exported from the target countries “free of collection of duties and estimated duties,” including those that could be imposed as a result of the circumvention investigation.[2] This relief is in effect until 24 months after the date of the proclamation (June 6, 2024) or until the emergency declared by the President is terminated, whichever is sooner. Commerce will issue regulations to implement this duty relief.[3]

    Commerce noted that the President’s decision means that CSPVs from the target countries will not be subject to any new antidumping or countervailing duties during this 24-month period. The President also expressed his commitment to the independence of the investigation carried out by Commerce, and Commerce has indicated that it intends to continue the circumvention inquiry “uninterrupted” and will apply the results of the inquiry “once this short-term emergency period is over.”[4]

    Ultimately, the takeaway here is that the circumvention inquiry will continue. However, if Commerce were to reach an affirmative circumvention determination, imports of CSPVs from the target countries would not be subject to increased duties based on that decision until June 6, 2024, or whenever the President determines that the emergency is over. If Commerce were to reach a negative determination, then no duties would be imposed on imports of CSPVs from the target countries after the end of the temporary relief period.

    The announcement is a much-needed reprieve to the solar industry that was experiencing canceled projects and layoffs because of the uncertainty caused by the initiation of the circumvention inquiry.

    INCREASING DOMESTIC PRODUCTION CAPABILITY AND DEMAND FOR SUCH PRODUCTS

    To boost US production of CSPVs, President Biden is also invoking the Defense Production Act (DPA)[5] to accelerate domestic production of CSPVs.[6] This may provide opportunities for a variety of federal incentives for CSPV production.

    Additionally, the President announced that he is using the federal government’s purchasing power to help support CSPV manufacturing. His announcement noted that this will include the following:

    1. Master Supply Agreements for domestically manufactured solar systems to increase the speed and efficiency with which domestic clean electricity providers can sell their products to the US government; and
    2. So-called “Super Preferences” to apply domestic content standards for federal procurement of solar systems, including domestically manufactured solar photovoltaic components, consistent with the Buy American Act.

    The pending circumvention inquiry will also presumably help spur domestic production of CSPVs as the solar industry does not want to face the same disruption wrought by the initiation of the circumvention inquiry at the end of the temporary relief period. The President stated that these moves are intended to stimulate domestic production of CSPVs, setting a goal of 15 gigawatts in increased domestic capacity by the end of his first term.

    Authors

    Carl J. Fleming

    Partner

    Washington, DC

    More insights

  • Half a Loaf Is Not Enough: Second Circuit Sustains Fraud Claim for Failure to Disclose SEC Investigation

    Half a Loaf Is Not Enough: Second Circuit Sustains Fraud Claim for Failure to Disclose SEC Investigation

    ARTICLE / CLIENT ALERT

    Half a Loaf Is Not Enough: Second Circuit Sustains Fraud Claim for Failure to Disclose SEC Investigation

    June 6, 2022

    Read time: 5 min

    Key takeaways
    Overview

    Companies under US Securities and Exchange Commission (SEC) investigation focus on marshaling the facts, defenses and related strategies during the course of the investigation and making presentations to the enforcement staff. However, there is also a parallel issue that companies often grapple with: whether the investigation should be publicly disclosed. In general, public companies under investigation are not required to disclose the existence of the investigation to the public. However, even without an independent duty to disclose, case law dictates that if a company speaks on an issue, it has a duty to tell the whole truth.[1]

    The US Court of Appeals for the Second Circuit’s recent decision in Noto v. 22nd Century Group, Inc. is a wake-up call for companies to consider disclosing an SEC investigation when they have disclosed the transactions or activities that are the subject of the investigation where there has otherwise been no disclosure of the investigation itself. Failure to do so may result in the sustaining of fraud claims in private litigation for not disclosing an SEC investigation.

    In depth

    In Noto, the complaint against a public company and two executives alleged that the defendants failed to disclose an SEC investigation into the company’s internal control over financial reporting. The company disclosed in SEC filings that management had concluded that material weaknesses existed in its internal control over financial reporting and that it had undertaken remediation efforts. Ultimately, in the Form 10-Q for the second quarter of 2018, the company disclosed that it completed its remediation plan that was targeted at eliminating the previously reported material weaknesses. Throughout the period of these disclosures, the company was aware that the SEC was investigating its internal controls. After online commentators revealed the SEC investigation and an alleged paid stock promotion scheme, the company’s price fell, and the plaintiffs alleged they were harmed.

    The district court dismissed the complaint, ruling that the company had no duty to disclose the investigation. The Second Circuit reversed, finding that the complaint adequately alleged that the defendants violated Rule 10b-5(b) by not mentioning the SEC investigation, thus making the disclosure of the internal control deficiencies misleading:

    Defendants had a duty to disclose the SEC investigation in light of specific statements they made about the Company’s accounting weaknesses… Because defendants here specifically noted the deficiencies and that they were working on the problem, and then stated that they had solved the issue, “the failure to disclose [the investigation] would cause a reasonable investor to make an overly optimistic assessment of the risk”… Indeed, the nondisclosure remained a material omission even after the Company represented that it had rectified the problem because the SEC investigation was ongoing.[2]

    Noto appears to be the first decision tying the duty to disclose an investigation to concurrent disclosures that the company has deficiencies and weaknesses in its internal control over financial reporting. A logical extension of the Second Circuit’s reasoning would apply to disclosures made about an issuer conducting an internal investigation. If, in addition to conducting an internal investigation, the SEC were investigating the matter, disclosing such an internal investigation without disclosing the SEC investigation would appear to run counter to the Court’s rationale for sustaining the fraud complaint.

    Disclosure issues related to governmental investigations are not likely to abate but are expected to grow as the Biden Administration ratchets up enforcement actions across many fronts, including financial reporting, antitrust, the Foreign Corrupt Practices Act (FCPA), false claims and consumer protection. That is certainly anticipated to be the case with SEC enforcement activity, with tough pronouncements emanating from the SEC Division of Enforcement’s leadership and the White House boosting the SEC’s proposed budget by more than 11% from fiscal year 2021 and boosting the Enforcement Division’s budget by $53 million.

    We can identify several measures to consider in assessing the disclosure issues, including:

    • Ensuring that individuals who would have information about an investigation participate in the company’s regular disclosure review process
    • Close collaboration between disclosure counsel and defense counsel to advise the company on whether there is a duty to disclose an investigation and/or strategic reasons for making a voluntary public disclosure. This collaboration would include advising on the requirements of Accounting Standard Codification 450 to determine whether disclosure of a loss contingency from a lawsuit or government investigation when the loss is required and an assessment of the disclosure requirements under items 103 and 303 of Regulation S-K.
    • Regular evaluation of the disclosure position and reassessment of materiality as the course of the investigation unfolds.

    Mary Ryan, a summer associate in the Washington, DC, office, also contributed to this article.

    Authors

    Eric Orsic

    Partner

    Chicago

    More insights